Calamos Advisors’s Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 MACC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,000
Closed -$2K 1576
2022
Q3
$2K Buy
+75,000
New +$5.83K ﹤0.01% 1258

Other funds holding MACC.WS

Calamos Advisors's MACC.WS Position: Q4 2022 in Review

Calamos Advisors sold out of Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (MACC.WS) in Q4 2022, closing a stake of 75,000 shares — an estimated $2K sold.

Calamos Advisors first reported a position in MACC.WS in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 1 fund tracked by Wall St. Rank holds MACC.WS as of Q4 2022.

  • Calamos Advisors reported no remaining Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 75,000 Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $2K.
  • Calamos Advisors first reported a position in Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q3 2022 and held it in 1 quarter.
  • Calamos Advisors's Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $2K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.